Publications & Presentations

  • All
  • Cell Engineering & Therapy
  • Checkpoint & Combination Immunotherapies
  • Inflammatory & Autoimmune Disease
  • Solid Tumor & Oncology
  • Vaccines and Immunology Research
Checkpoint & Combination Immunotherapies / Publication / 2019
Daver N, Kantarjian H, Mackay S, Flynn B, Basu S, Garcia-Manero G, Alfayez M, Konopleva M, Matthews J, Kornblau S, Jabbour E, Zhou J, Andreeff M; IsoPlexis, Branford, CT., Polyfunctionality determined by single-cell proteomics of bone marrow-derived CD4 T cells from patients with acute myeloid leukemia identifies patients responding to anti-PD-1-based therapy and discovers profound T cell defect in mutant TP53 disease., Presented at the AACR Conference, 2019
Inflammatory & Autoimmune Disease / Publication / 2018
Fujiwara M, Anstadt EJ, Flynn B, Morse K, Ng C, Paczkowski P, Zhou J, Mackay S, Wasko N, Nichols F, Clark RB.,  Enhanced TLR2 Responses in Multiple Sclerosis., Clinical and Experimental Immunology., 2018
Cell Engineering & Therapy / Presentation / 2017
Fraietta JA, Lacey SF, Orlando E, Pruteanu J, Gohil M, Wang Y, Boesteanu A, O'Connor R, Ambrose DE, Hwang WT, Wilcox N, Bedoya F, Dorfmeier C, Chen F, Parakandi H, Gupta M, Pequignot E, Johnson FB, Kulikovskaya I, Liu L, Lundh SM, Xu J, Davis MM, Young RM, Levine BL, Siegel DL, Huang A, Wherry EJ, Zhou J, Paczkowski P, Mackay S, Brogdon J, Bitter H, Porter DL, June CH, and Melenhorst JJ.,  Identification of Functional Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy of Chronic Lymphocytic Leukemia., Blood 130 (Suppl. 1) 3181 ., 2017